129 related articles for article (PubMed ID: 33360358)
1. A nationwide population-based study on overall survival after meningioma surgery.
Champeaux-Depond C; Weller J; Froelich S; Resche-Rigon M
Cancer Epidemiol; 2021 Feb; 70():101875. PubMed ID: 33360358
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 2: A nationwide population-based study focused on survival after meningioma surgery.
Champeaux-Depond C; Weller J; Resche-Rigon M
Clin Neurol Neurosurg; 2020 Nov; 198():106236. PubMed ID: 33002675
[TBL] [Abstract][Full Text] [Related]
3. Cause-Specific Survival After Meningioma Surgery: A Nationwide Population-Based Competing Risk Study.
Champeaux-Depond C; Constantinou P; Weller J
World Neurosurg; 2021 Feb; 146():e67-e75. PubMed ID: 33096279
[TBL] [Abstract][Full Text] [Related]
4. Outcome After Protontherapy for Progression or Recurrence of Surgically Treated Meningioma.
Champeaux-Depond C; Weller J
Brain Tumor Res Treat; 2021 Oct; 9(2):46-57. PubMed ID: 34725984
[TBL] [Abstract][Full Text] [Related]
5. Relative survival after meningioma surgery. A French nationwide population-based cohort study.
Champeaux-Depond C; Constantinou P; Tuppin P; Resche-Rigon M; Weller J
Br J Neurosurg; 2022 Dec; ():1-7. PubMed ID: 36576058
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen. A treatment for meningioma?
Champeaux-Depond C; Weller J
Cancer Treat Res Commun; 2021; 27():100343. PubMed ID: 33647870
[TBL] [Abstract][Full Text] [Related]
7. Cyproterone acetate and meningioma: a nationwide-wide population based study.
Champeaux-Depond C; Weller J; Froelich S; Sartor A
J Neurooncol; 2021 Jan; 151(2):331-338. PubMed ID: 33394263
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and Survival after Spinal Meningioma Surgery: A Nationwide Population-Based Study.
Jecko V; Weller J; Houston D; Champeaux-Depond C
Asian Spine J; 2022 Dec; 16(6):865-873. PubMed ID: 35051328
[TBL] [Abstract][Full Text] [Related]
9. Five-year cause-specific survival after meningioma surgery. A nationwide population-based study.
Champeaux-Depond C; Weller J; Constantinou P; Tuppin P; Froelich S
Neurochirurgie; 2022 Apr; 68(3):280-288. PubMed ID: 34906556
[TBL] [Abstract][Full Text] [Related]
10. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
11. Atypical meningioma. A study on recurrence and disease-specific survival.
Champeaux C; Houston D; Dunn L
Neurochirurgie; 2017 Sep; 63(4):273-281. PubMed ID: 28882609
[TBL] [Abstract][Full Text] [Related]
12. Gamma Knife radiosurgery for intracranial benign meningiomas: follow-up outcome in 130 patients.
Ge Y; Liu D; Zhang Z; Li Y; Lin Y; Wang G; Zong Y; Liu E
Neurosurg Focus; 2019 Jun; 46(6):E7. PubMed ID: 31153153
[TBL] [Abstract][Full Text] [Related]
13. Single-fraction radiosurgery of benign intracranial meningiomas.
Pollock BE; Stafford SL; Link MJ; Brown PD; Garces YI; Foote RL
Neurosurgery; 2012 Sep; 71(3):604-12; discussion 613. PubMed ID: 22710378
[TBL] [Abstract][Full Text] [Related]
14. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
15. Gamma Knife radiosurgery of large skull base meningiomas.
Starke RM; Przybylowski CJ; Sugoto M; Fezeu F; Awad AJ; Ding D; Nguyen JH; Sheehan JP
J Neurosurg; 2015 Feb; 122(2):363-72. PubMed ID: 25479122
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of meningiomas. A nationwide study of surgically treated tumours on French medico-administrative data.
Champeaux C; Weller J; Katsahian S
Cancer Epidemiol; 2019 Feb; 58():63-70. PubMed ID: 30481723
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience.
Pollock BE; Stafford SL; Link MJ; Garces YI; Foote RL
Cancer; 2012 Feb; 118(4):1048-54. PubMed ID: 21773968
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
19. Meningiomas in children and adolescents: a meta-analysis of individual patient data.
Kotecha RS; Pascoe EM; Rushing EJ; Rorke-Adams LB; Zwerdling T; Gao X; Li X; Greene S; Amirjamshidi A; Kim SK; Lima MA; Hung PC; Lakhdar F; Mehta N; Liu Y; Devi BI; Sudhir BJ; Lund-Johansen M; Gjerris F; Cole CH; Gottardo NG
Lancet Oncol; 2011 Dec; 12(13):1229-39. PubMed ID: 22094004
[TBL] [Abstract][Full Text] [Related]
20. Long-term 25-year follow-up of surgically treated parasagittal meningiomas.
Pettersson-Segerlind J; Orrego A; Lönn S; Mathiesen T
World Neurosurg; 2011 Dec; 76(6):564-71. PubMed ID: 22251505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]